Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -296000.00% is 48% below its 5-year average of -200401.42%, near the high end of its 5-year range (-1175800.00%–19690.91%).
59.41% below its 12-month average of -185684.62%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-296000.00%
NET PROFIT MARGIN AVG TTM
-185684.62%
NET PROFIT MARGIN AVG 3Y
-275385.60%
NET PROFIT MARGIN AVG 5Y
-200401.42%
NET PROFIT MARGIN AVG 10Y
-23252.46%
NET PROFIT MARGIN AVG 15Y
-9693.29%
NET PROFIT MARGIN AVG 20Y
-239.54%
CURRENT VS TTM AVG
-59.41%
CURRENT VS 3Y AVG
-7.49%
CURRENT VS 5Y AVG
-47.70%
CURRENT VS 10Y AVG
-1172.98%
CURRENT VS 15Y AVG
-2953.66%
CURRENT VS 20Y AVG
-123472.40%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-113846053.85%
vs the sector median at left
Altimmune, Inc.
Market Cap
$519.25M
Net Profit Margin
-296000.00%
TTM Avg
-185684.62%
3Y Avg
-275385.60%
5Y Avg
-200401.42%
Market Cap
$516.76M
Net Profit Margin
-921.50%
TTM Avg
-767.53%
3Y Avg
-527.58%
5Y Avg
-706.89%
Market Cap
$524.43M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$529.58M
Net Profit Margin
-5256.80%
TTM Avg
-3099.51%
3Y Avg
-6775.80%
5Y Avg
-4603.58%
Market Cap
$531.52M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$531.98M
Net Profit Margin
0.56%
TTM Avg
-33.88%
3Y Avg
-929.83%
5Y Avg
-984.73%
Market Cap
$505.87M
Net Profit Margin
-56.68%
TTM Avg
-93.15%
3Y Avg
-82.60%
5Y Avg
-71.77%
Market Cap
$533.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$504.04M
Net Profit Margin
-1371.51%
TTM Avg
-709.80%
3Y Avg
-108166.39%
5Y Avg
-73106.10%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Altimmune, Inc. (ALT) | $519.25M | -296000.00% | -185684.62% | -275385.60% | -200401.42% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $516.76M | -921.50% | -767.53% | -527.58% | -706.89% |
| Immix Biopharma, Inc. (IMMX)vs › | $524.43M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shattuck Labs, Inc. (STTK)vs › | $529.58M | -5256.80% | -3099.51% | -6775.80% | -4603.58% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $531.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| Delcath Systems, Inc. (DCTH)vs › | $531.98M | 0.56% | -33.88% | -929.83% | -984.73% |
| 908 Devices Inc. (MASS)vs › | $505.87M | -56.68% | -93.15% | -82.60% | -71.77% |
| Monopar Therapeutics Inc. (MNPR)vs › | $533.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| Crescent Biopharma, Inc. (CBIO)vs › | $504.04M | -1371.51% | -709.80% | -108166.39% | -73106.10% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.93M | -3566.68% | -585431.82% | -433391.80% | -288954.46% |
Operating Margin
-230461.0%
Net Profit Margin
-296000.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -105223.08% |
| 2025-09-30 | -380280.00% |
| 2025-06-30 | -442920.00% |
| 2025-03-31 | -391500.00% |
| 2024-12-31 | -463600.00% |
| 2024-09-30 | -456900.00% |
| 2024-06-30 | -492800.00% |
| 2024-03-31 | -487880.00% |
| 2023-12-31 | -85516.22% |
| 2023-09-30 | -5710.22% |
| 2023-06-30 | -267683.33% |
| 2023-03-31 | -95590.48% |
| 2022-12-31 | 19690.91% |
| 2022-09-30 | -1175800.00% |
| 2022-06-30 | -251337.50% |
| 2022-03-31 | -60718.75% |
| 2021-12-31 | -728.99% |
| 2021-09-30 | -21208.86% |
| 2021-06-30 | -18121.90% |
| 2021-03-31 | -1773.75% |
| 2020-12-31 | -459.28% |
| 2020-09-30 | -604.84% |
| 2020-06-30 | -2323.46% |
| 2020-03-31 | -175.61% |
| 2019-12-31 | -711.47% |
| 2019-09-30 | -1698.71% |
| 2019-06-30 | -208.29% |
| 2019-03-31 | -70.96% |
| 2018-12-31 | -946.73% |
| 2018-09-30 | -89.25% |
| 2018-06-30 | -378.08% |
| 2018-03-31 | -64267.68% |
| 2017-12-31 | -314.40% |
| 2017-09-30 | -651.25% |
| 2017-06-30 | -62988.70% |
| 2017-03-31 | -273.31% |
| 2016-12-31 | 6950.52% |
| 2016-09-30 | 10990.71% |
| 2016-06-30 | 381.03% |
| 2016-03-31 | -122.00% |
| 2015-12-31 | -97.78% |
| 2015-09-30 | -114.62% |
| 2015-06-30 | -203.64% |
| 2015-03-31 | 20.70% |
| 2014-12-31 | -143.97% |
| 2014-09-30 | -480.90% |
| 2014-06-30 | -12.00% |
| 2014-03-31 | -60.35% |
| 2013-12-31 | -121.09% |
| 2013-09-30 | -113.12% |
| 2013-06-30 | -28.78% |
| 2013-03-31 | -32.61% |
| 2012-12-31 | -21.11% |
| 2012-09-30 | -3.19% |
| 2012-06-30 | -11.98% |
| 2012-03-31 | -43.58% |
| 2011-12-31 | 12.01% |
| 2011-09-30 | -0.64% |
| 2011-06-30 | -37.92% |
| 2011-03-31 | -32.75% |
| 2010-12-31 | -236.13% |
| 2010-09-30 | -69.32% |
| 2010-06-30 | -133.75% |
| 2010-03-31 | -254.91% |
| 2009-12-31 | -79.59% |
| 2009-09-30 | -204.42% |
| 2009-06-30 | -82.17% |
| 2009-03-31 | -108.89% |
| 2008-12-31 | -94.92% |
| 2008-09-30 | -40.67% |
| 2008-06-30 | -200.22% |
| 2008-03-31 | -85.92% |
| 2007-12-31 | -85.51% |
| 2007-09-30 | -9.40% |
| 2007-06-30 | -9.40% |
| 2007-03-31 | 70.12% |
| 2006-12-31 | 46.09% |
| 2006-09-30 | 62.16% |
| 2006-06-30 | 60.92% |
| 2006-03-31 | 50.48% |
| 2005-12-31 | 35.10% |
| 2005-09-30 | 71.01% |
| 2005-06-30 | 0.00% |
